Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

76.24USD
18 Dec 2018
Change (% chg)

$-0.76 (-0.99%)
Prev Close
$77.00
Open
$77.46
Day's High
$78.59
Day's Low
$75.45
Volume
329,052
Avg. Vol
279,050
52-wk High
$106.26
52-wk Low
$75.45

Select another date:

Tue, Oct 2 2018

AmerisourceBergen to pay $625 million in U.S. civil fraud settlement

NEW YORK AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.

UPDATE 4-AmerisourceBergen to pay $625 mln in U.S. civil fraud settlement

NEW YORK, Oct 1 AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.

AmerisourceBergen in $625 mln drug distribution settlement, New York says

NEW YORK, Oct 1 AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.

UPDATE 1-U.S. subpoenas AmerisourceBergen over opioid products

Aug 2 Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

U.S. subpoenas AmerisourceBergen over opioid products

Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

U.S. subpoenas AmerisourceBergen over opioid products

Aug 2 Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

Select another date: